Involvement of DNA polymerase beta in repairing oxidative damages induced by antitumor drug adriamycin

Toxicology and Applied Pharmacology

Volumn 246, Issue 3, 2010, Pages 163-170

  Liu, Shukun ^a   Wu, Mei ^a   Zhang, Zunzhen ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Adriamycin; Base excision repair; DNA polymerase beta; Drug resistance; Reactive oxygen species

Indexed keywords

DNA DIRECTED DNA POLYMERASE BETA; DOXORUBICIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; CHEMOSENSITIVITY; CHROMOSOME DAMAGE; COLORIMETRY; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DIAGNOSTIC KIT; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; EMBRYO; ENZYME ACTIVITY; FIBROBLAST; GENE FREQUENCY; GENE MUTATION; HOMOZYGOTE; MICRONUCLEUS TEST; MOUSE; NONHUMAN; WILD TYPE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; DNA BREAKS; DNA DAMAGE; DNA POLYMERASE BETA; DNA REPAIR; DOXORUBICIN; DRUG HYPERSENSITIVITY; FIBROBLASTS; MICE; MUTATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

MURINAE;

EID: 77956876035     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.05.011     Document Type: Article

References (35)

1. Anderson R.D., Berger N.A. International Commission for Protection Against Environmental Mutagens and Carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents. Mutat. Res. 1994, 309:109-142. [PubMed: 7519727].
2. Barnett Y.A., Warnoc C.A., Gillespie E.S., Barnett C.R., Livingstone M.B. Effect of dietary intake and lifestyle factors on in vivo mutant frequency at the HPRT gene locus in healthy human subjects. Mutat. Res. 1999, 431:305-315. PubMed:10635996.
3. Canitrot Y., Cazaux C., Fréchet M., Bouayadi K., Lesca C., Salles B., Hoffmann J.S. Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. Proc. Natl. Acad. 1998, 95:12586-12590. PubMed: 9770529.
4. Chen Z., Li X., Lu Y. Impact of 1.8-GHz radiofrequency radiation (RFR) on DNA damage and repair induced by doxorubicin in human B-cell lymphoblastoid cells. Mutat. Res. 2010, 695:16-21. PubMed: 19833226.
5. Cordes N., van Beuningen D. Arrest of human lung fibroblasts in G2 phase after irradiation is regulated by converging phosphatidylinositol-3 kinase and beta1-integrin signaling in vitro. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58:453-462. [PubMed: 14751515].
6. Eruslanov E., Kusmartsev S. Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol. Biol. 2010, 594:57-72. PubMed: 20072909.
7. Fenech M. The in vitro micronucleus technique. Mutat. Res. 2000, 455:81-95. PubMed: 11113469.
8. Fink D., Nebel S., Aebi S., Zheng H., Cenni B., Nehmé A., Howell S.B., Christen R.D. The role of DNA mismatch repair in platinum drug resistance. Cancer Res. 1996, 56:4881-4886. PubMed: 8895738.
9. Fishel M.L., He Y., Smith M.L., Kelley M.R. Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide. Cancer Res. 2007, 13:260-267. PubMed: 17200364.
10. Gillet J.P., Gottesman M.M. Mechanisms of multidrug resistance in cancer. Methods Mol Biol. 2010, 596:47-76. [PubMed: 19949920].
11. Horton J.K., Baker A., Berg B.J., Sobol R.W., Wilson S.H. Involvement of DNA polymerase beta in protection against the cytotoxicity of oxidative DNA damage. DNA Repair (Amst) 2002, 29:317-333. PubMed: 12509250.
12. Iwatsuki M., Mimori K., Yokobori T., Tanaka F., Tahara K., Inoue H., Baba H., Mori M. A platinum agent resistance gene, pol β, is a prognostic indicator in colorectal cancer. J. Surg. Oncol. 2009, 100:261-266. PubMed: 19330779.
13. Jaiswal A.S., Banerjee S., Panda H. A novel inhibitor of DNA polymerase beta enhances the ability of temozolomide to impair the growth of colon cancer cells. Mol. Cancer. Res. 2009, 7:73-83. PubMed: 19996303.
14. Köberle B., Masters J.R., Hartley J.A., Wood R.D. Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours. Curr. Biol. 1999, 9:273-276. PubMed:11397400.
15. Liu S., Cao J., An H., Shun H., Yang L., Liu Y. Analysis of spontaneous, gamma ray- and ethylnitrosourea-induced hprt mutants in HL-60 cells with multiplex PCR. World J. Gastroenterol. 2003, 9:578-583. PubMed: 12632522.
16. Lou H., Kaur K., Sharma A.K., Singal P.K. Adriamycin-induced oxidative stress, activation of MAP kinases and apoptosis in isolated cardiomyocytes. Pathophysiology 2006, 13:103-109. PubMed: 16580821.
17. Luo M., Kelley M.R. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone. Anticancer. Res. 2004, 24:2127-2134. PubMed: 15330152.
18. Matijasevic Z., Volkert M.R. Base excision repair sensitizes cells to sulfur mustard and chloroethyl ethyl sulfide. DNA Repair (Amst) 2007, 6:733-741. PubMed: 17292678.
19. Matsumoto Y., Kim K. Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair. Science 1995, 269:699-702. PubMed: 7624801.
20. Meng Q., Henderson R.F., Long L., Blair L., Walker D.M., Upton P.B., Swenberg J.A., Walker V.E. Mutagenicity at the Hprt locus in T cells of female mice following inhalation exposures to low levels of 1,3-butadiene. Chem. Biol. Interact. 2001, 135-136:343-361. PubMed:11397400.
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63. PubMed: 6606682.
22. Muñoz-Gámez J.A., Martín-Oliva D., Aguilar-Quesada R., Cañuelo A., Nuñez M.I., Valenzuela M.T., Ruiz de Almodóvar J.M., De Murcia G., Oliver F.J. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis. Biochem. J. 2005, 386:119-125. PubMed: 15456408.
23. Olive P.L., Banáth J.P., Durand R.E. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. Radiat. Res. 1990, 122:86-94. PubMed: 2320728.
24. Plummer E.R., Calvert H. Targeting poly(ADP-ribose) polymerase: a two-armed strategy for cancer therapy. Clin. Cancer Res. 2007, 13:6252-6256. PubMed: 17975135.
25. Quiles J.L., Huertas J.R., Battino M., Mataix J., Ramírez-Tortosa M.C. Antioxidant nutrients and adriamycin toxicity. Toxicology 2002, 180:79-95. PubMed: 12324201.
26. Saffi J., Saffi J., Agnoletto M.H., Guecheva T.N., Batista L.F., Carvalho H., Henriques J.A., Stary A., Menck C.F., Sarasin A. Effect of the anti-neoplastic drug doxorubicin on XPD-mutated DNA repair-deficient human cells. DNA Repair (Amst) 2010, 9:40-47. PubMed: 19926538.
27. Sobol R.W., Horton J.K., Kuhn R., Gu H., Singhal R.K., Prasad R., Rajewsky K., Wilson S.H. Requirement of mammalian DNA polymerase-β in base-excision repair. Nature 1996, 379:183-186. PubMed: 8538772.
28. Spencer D.M., Bilardi R.A., Koch T.H., Post G.C., Nafie J.W., Kimura K., Cutts S.M., Phillips D.R. DNA repair in response to anthracycline-DNA adducts: a role for both homologous recombination and nucleotide excision repair. Mutat. Res. 2008, 638:110-121. PubMed: 17961607.
29. Sugo N., Aratani Y., Nagashima Y., Kubota Y., Koyama H. Neonatal lethality with abnormal neurogenesis in mice deficient in DNA polymerase beta. EMBO J. 2000, 19:1397-1404. PubMed: 10716939.
30. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000, 35:206-221. PubMed: 10737956.
31. Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 1999, 27:612-616. PubMed: 10490282.
32. Wei Q., Cheng L., Xie K., Bucana C.D., Dong Z. Direct correlation between DNA repair capacity and metastatic potential of K-1735 murine melanoma cells. J. Invest. Dermatol. 1997, 108:3-6. PubMed: 8980277.
33. Wu M., Zhang Z., Che W. Suppression of a DNA base excision repair gene, hOGG1, increases bleomycin sensitivity of human lung cancer cell line. Toxicol. Appl. Pharmacol. 2008, 228:395-402. PubMed: 18234257.
34. Yang J., Parsons J., Caporali S., Nicolay N.H., Harrington C.F., Singh R., Finch D., D'Atri S., Farmer P.B., Johnston P.G., Mckenna W.G., Dianov G., Sharma R.A. Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy. Oncogene 2010, 29:463-468. PubMed: 19838217.
35. Zhu Y., Hu J., Hu Y., Liu W. Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance. Cancer Treat. Rev. 2009, 35:590-596. PubMed: 19635647.